Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 8, 2025 • 3:00 AM ET

Date/Time Source News Release
05/08/2025 04:05 PM EDT GlobeNewswire Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
05/01/2025 08:00 AM EDT GlobeNewswire Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025
04/15/2025 08:00 AM EDT GlobeNewswire Lisata Therapeutics Announces Research License with Catalent
03/06/2025 08:30 AM EST GlobeNewswire Lisata Therapeutics to Present at the Investival Showcase USA
03/05/2025 08:30 AM EST GlobeNewswire Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development
02/27/2025 04:05 PM EST GlobeNewswire Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
02/20/2025 08:00 AM EST GlobeNewswire Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025
02/05/2025 08:30 AM EST GlobeNewswire Lisata Therapeutics to Present at the 2025 BIO CEO & Investor Conference
01/23/2025 08:00 AM EST GlobeNewswire Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarcinoma
01/22/2025 08:00 AM EST GlobeNewswire Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
Page

Additional News

As of June 8, 2025 • 3:00 AM ET

Date/Time Source News Release
05/09/2025 12:40 AM EDT SeekingAlpha Lisata Therapeutics GAAP EPS of -$0.55 misses by $0.02
05/08/2025 09:57 PM EDT SeekingAlpha Lisata outlines data-rich year ahead with multiple clinical milestones for Certepetide
05/08/2025 09:57 PM EDT SeekingAlpha Lisata Therapeutics, Inc. (LSTA) Q1 2025 Earnings Conference Call Transcript
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Lisata Therapeutics Inc.
05/07/2025 12:40 PM EDT SeekingAlpha Lisata Therapeutics Q1 2025 Earnings Preview
02/27/2025 10:06 PM EST SeekingAlpha Lisata Therapeutics, Inc. (LSTA) Q4 2024 Earnings Call Transcript
02/27/2025 04:13 PM EST SeekingAlpha Lisata Therapeutics GAAP EPS of -$2.40 beats by $0.22, revenue of $1M
02/27/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, February 27th, 2025
02/27/2025 04:30 AM EST US Earnings Reports Expected earnings - Lisata Therapeutics Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.